TETERBORO, N.J., Sept. 15 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Robert A. Hagemann, Vice President
and Chief Financial Officer, is scheduled to speak at the Banc of America
Securities 33rd Annual Investment Conference on Tuesday, September 16, 2003,
at the Ritz-Carlton Hotel in San Francisco, California. The Quest Diagnostics
presentation is scheduled to begin at 8:30 a.m. Pacific Time
(11:30 a.m. Eastern Time).
The presentation will be webcast live during the conference and will be
available to registered investors on the following site:
http://www.veracast.com/webcasts/bas/33rd-annual-2003/id47104351.cfm and to
the public on http://www.questdiagnostics.com. An additional link for the
breakout session will be available on the following site:
http://www.veracast.com/webcasts/bas/33rd-annual-2003/id69105778.cfm In
addition, the archived webcast will be available starting approximately three
hours after the actual presentation time and will be available through Friday,
October 3, 2003.
Quest Diagnostics Incorporated is the nation's leading provider of
diagnostic testing, information and services, providing insights that enable
physicians, hospitals, managed care organizations and other healthcare
professionals to make decisions to improve health. The company offers the
broadest access to diagnostic laboratory services through its national network
of laboratories and patient service centers. Quest Diagnostics is the leading
provider of esoteric testing, including gene-based medical testing, and
empowers healthcare organizations and clinicians with state-of-the-art
connectivity solutions that improve practice management. Additional company
information can be found on the Internet at: http://www.questdiagnostics.com.
The statements in this press release which are not historical facts or
information may be forward-looking statements. These forward-looking
statements involve risks and uncertainties that could cause actual results and
outcomes to be materially different. Certain of these risks and uncertainties
may include, but are not limited to, unanticipated expenditures, changing
relationships with customers, suppliers and strategic partners, conditions of
the economy and other factors described in the Quest Diagnostics Incorporated
2002 Form 10-K and subsequent filings.
SOURCE Quest Diagnostics Incorporated
-0- 09/15/2003
/CONTACT: Laure Park, Investors, +1-201-393-5030, or Gary Samuels, Media,
+1-201-393-5700, both of Quest Diagnostics/
/Web site: http://www.questdiagnostics.com
http://www.veracast.com/webcasts/bas/33rd-annual-2003/id47104351.cfm
http://www.veracast.com/webcasts/bas/33rd-annual-2003/id69105778.cfm /
(DGX)